ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
NexGel Inc

NexGel Inc (NXGL)

3.66
0.06
( 1.67% )
업데이트: 02:23:45

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
3.66
매수가
3.61
매도가
3.74
거래량
12,490
3.55 일간 변동폭 3.70
1.84 52주 범위 5.10
market_cap
전일 종가
3.60
개장가
3.65
최근 거래 시간
90
@
3.64
마지막 거래 시간
02:30:25
재정 규모
US$ 45,223
VWAP
3.6208
평균 볼륨(3m)
137,779
발행 주식
6,790,777
배당수익률
-
주가수익률
-7.77
주당순이익(EPS)
-0.46
매출
4.09M
순이익
-3.16M

NexGel Inc 정보

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels a... NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company recognizes revenue from contract manufacturing. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
NexGel Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker NXGL. The last closing price for NexGel was US$3.60. Over the last year, NexGel shares have traded in a share price range of US$ 1.84 to US$ 5.10.

NexGel currently has 6,790,777 shares in issue. The market capitalisation of NexGel is US$24.45 million. NexGel has a price to earnings ratio (PE ratio) of -7.77.

NXGL 최신 뉴스

NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third...

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing Gross profit margin for the quarter was 43.6% compared to 28.2% in...

NEXGEL Announces $2,000,000 Registered Direct Offering

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...

NEXGEL to Participate in Upcoming October Investor Conferences

LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially

LANGHORNE, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection

LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical and over-the-counter (OTC) products including...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.277.964601769913.393.7383.2760713.40399662CS
4-0.7-16.05504587164.364.5253.11399293.60187303CS
120.841529.8563065462.81855.12.761377793.87790575CS
260.6220.39473684213.045.12.27861733.54780244CS
521.461.94690265492.265.11.84570483.30217759CS
1561.1646.42.55.11.09500232.47441156CS
260-0.74-16.81818181824.45.11.09754042.72724481CS

NXGL - Frequently Asked Questions (FAQ)

What is the current NexGel share price?
The current share price of NexGel is US$ 3.66
How many NexGel shares are in issue?
NexGel has 6,790,777 shares in issue
What is the market cap of NexGel?
The market capitalisation of NexGel is USD 24.45M
What is the 1 year trading range for NexGel share price?
NexGel has traded in the range of US$ 1.84 to US$ 5.10 during the past year
What is the PE ratio of NexGel?
The price to earnings ratio of NexGel is -7.77
What is the cash to sales ratio of NexGel?
The cash to sales ratio of NexGel is 6
What is the reporting currency for NexGel?
NexGel reports financial results in USD
What is the latest annual turnover for NexGel?
The latest annual turnover of NexGel is USD 4.09M
What is the latest annual profit for NexGel?
The latest annual profit of NexGel is USD -3.16M
What is the registered address of NexGel?
The registered address for NexGel is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the NexGel website address?
The website address for NexGel is nexgel.com
Which industry sector does NexGel operate in?
NexGel operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
FOXXFoxx Development Holdings Inc
US$ 10.1699
(251.90%)
17.71M
AMODAlpha Modus Holdings Inc
US$ 3.6599
(137.66%)
109.59M
TECXTectonic Therapeutic Inc
US$ 56.52
(119.75%)
4.05M
ACONAclarion Inc
US$ 16.14
(75.20%)
1.68M
ATHEAlterity Therapeutics Limited
US$ 4.80
(64.95%)
19.78M
CLEUChina Liberal Education Holdings Ltd
US$ 0.19
(-97.55%)
145.06M
CRGXCARGO Therapeutics Inc
US$ 3.40
(-74.22%)
15.96M
EVTVEnvirotech Vehicles Inc
US$ 0.3727
(-44.12%)
2.88M
FATFAT Brands Inc
US$ 3.3899
(-42.25%)
178.68k
IRWDIronwood Pharmaceuticals Inc
US$ 2.33
(-37.37%)
6.1M
NVDANVIDIA Corporation
US$ 119.64
(-3.28%)
190.6M
CLEUChina Liberal Education Holdings Ltd
US$ 0.19
(-97.55%)
145.06M
MGOLMGO Global Inc
US$ 0.12105
(19.03%)
140.28M
AMODAlpha Modus Holdings Inc
US$ 3.6698
(138.30%)
108.48M
SPGCSacks Parente Golf Inc
US$ 0.7853
(33.10%)
102.98M

NXGL Discussion

게시물 보기
81vette 81vette 1 월 전
3 month uptrend,increasing volume surges, great indicator of continuing up
👍️0
81vette 81vette 1 월 전
Thru $5 is good,could get interesting!
👍️0
81vette 81vette 1 월 전
Waking up again!
👍️0
TrendTrade2016 TrendTrade2016 1 월 전
NXGL 5 BUCKS RING A DING!!
👍️0
TrendTrade2016 TrendTrade2016 2 월 전
NXGL LETS SEE 5 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 2 월 전
NXGL MASSIVE BREAK
👍️0
TrendTrade2016 TrendTrade2016 2 월 전
NXGL BEAUTIFUL WEEKLY BREAK OUT
👍️0
TrendTrade2016 TrendTrade2016 3 월 전
NXGL...MY NEXT BIO BEAST READY TO ROAR THROUGH WALL STREET
👍️0
Monksdream Monksdream 3 월 전
NXGL, new 52 week high
👍️0
81vette 81vette 3 월 전
Looks like flipping the warrents would have been good last few days
👍️0
Helter Skelter Helter Skelter 4 월 전
Expecting earnings report around Nov 14th...🤪
👍️0
Helter Skelter Helter Skelter 4 월 전
Hey 81vette, expecting earnings' NEWS any moment/day.
Also anticipating a PROFIT which should send $NXGL, I'm thinking...😺
👍️0
81vette 81vette 4 월 전
Hey bro,good to see you,yes it’s been stairstepping up nicely since early 2023
Thanks for reminding me about it!!
👍️0
Helter Skelter Helter Skelter 4 월 전
Looking for 100% gain from here (2.80) when earnings are released around Nov. 14, 2024.

As of August 13, 2024, the registrant had 6,324,266 shares of common stock outstanding.



$NXGL



👉️ NXGL 10Q Period Ending June 30, 2024
👍️0
Monksdream Monksdream 8 월 전
NXGL under $3
👍️0
tdag910 tdag910 11 월 전
Winner winner chicken dinner!!
👍️0
Pinksatthehotel Pinksatthehotel 11 월 전
Looking good!
👍️0
tdag910 tdag910 1 년 전
Anybody home?
👍️0
alyck alyck 2 년 전
NXGL looking great! Solidly over $2 and volume increasing. Keep it going
👍️0
81vette 81vette 2 년 전
Ended @New 52 week high,blue sky babe!! Enjoy the weekend everyone!!
👍️0
81vette 81vette 2 년 전
contracts with pro sports teams will make brand huge,building a great company,investment in packaging plant was wise
👍️0
81vette 81vette 2 년 전
For the first quarter of 2023, revenue totaled $620 thousand and increased by $224 thousand, or 56.6%, compared to $396 thousand for the same period the year prior. The increase in overall revenues was primarily due to sales growth in both contract manufacturing and branded products. Revenue during the first quarter of 2023 includes one full month of revenue contribution from the Company’s newly formed joint venture with C.G. Laboratories.first quarter we delivered 56.6% revenue growth year-over-year, driven by increased sales in contract manufacturing and branded consumer products. We also started to see contribution in March from our new joint venture with CG Labs. During the quarter, we launched several new products and invested strategically in sales and marketing to support those launches. We are already starting to see the financial returns from these investments in the second quarter, as well as from our new JV.” “Based on the dynamic changes to our business, which include the March 1 joint venture, I feel it’s important to provide a one-time exception to our policy of not providing guidance. Based on these developments and our progress to date, we are projecting $1.0 million in revenue for the second quarter of 2023, an increase of 78.2% year-over-year. Complementing this, we had approximately $5.8 million in cash and cash equivalents at quarter-end, which gives us sufficient runway to operate and the ability to be opportunistic about further potential investments to accelerate our growth.”Acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business.
Executed a supply agreement with a large new customer relating to a new consumer product.Launched advertising and marketing initiative, which has increased branded product sales.
👍️ 1
81vette 81vette 2 년 전
watch demand,next move up thru 52 week high,very low supply atm
👍️0
81vette 81vette 2 년 전
GOLDEN CROSS is best indicator of long bulls,follow the money is the saying
👍️0
81vette 81vette 2 년 전
eps q/q up 60%,is why moving up,big profit coming,great future $ deals,expect institutions loading long,way undervalued@ 10M mkt cap
👍️0
81vette 81vette 2 년 전
GOLDEN CROSS now,thru triple top res.,52week high>$2.00,then blue sky
👍️0
81vette 81vette 2 년 전
4M float,5M o/s,.52%short,buy vol 15X ave,not optionable,shares borrow ava. dropped 400% with pre-mkt volume,easily could go ZERO BORROW with this low float/os
👍️0

최근 히스토리

Delayed Upgrade Clock